awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34541893-62CD9BA4-D8F4-4023-BFCE-C705A74045D8
Q34541893-62CD9BA4-D8F4-4023-BFCE-C705A74045D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34541893-62CD9BA4-D8F4-4023-BFCE-C705A74045D8
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
P2860
Q34541893-62CD9BA4-D8F4-4023-BFCE-C705A74045D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34541893-62CD9BA4-D8F4-4023-BFCE-C705A74045D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ed6edf2c462a26c6c1d0dbc7ae42df895980c9f
P2860
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.